The diagnostic indicators of gestational diabetes mellitus from second trimester to birth: a systematic review
Authors:
Open Access
- 11 October 2021
- journal article
- review article
- Published by Springer Nature in Clinical Diabetes and Endocrinology
- Vol. 7 (1) , 1-15
Abstract
Background: Gestational diabetes mellitus (GDM) is glucose intolerance first recognised during pregnancy. Both modalities and thresholds of the GDM diagnostic test, the Oral Glucose Tolerance Test (OGTT), have varied widely over time and among countries. Additionally, OGTT limitations include inconsistency, poor patient tolerability, and questionable diagnostic reliability. Many biological parameters have been reported to be modified by GDM and could potentially be used as diagnostic indicators. This study aimed to 1) systematically explore biomarkers reported in the literature as differentiating GDM from healthy pregnancies 2) screen those indicators assessed against OGTT to propose OGTT alternatives.Main body: A systematic review of GDM diagnostic indicators was performed according to PRISMA guidelines (PROSPERO registration CRD42020145499). Inclusion criteria were full-text, comprehensible English-language articles published January 2009-January 2021, where a biomarker (from blood, ultrasound, amniotic fluid, placenta) was compared between GDM and normal glucose tolerance (NGT) women from the second trimester onward to immediately postpartum. GDM diagnostic method had to be clearly specified, and the number of patients per study higher than 30 in total or 15 per group. Results were synthesised by biomarkers.Results: Of 13,133 studies identified in initial screening, 174 studies (135,801 participants) were included. One hundred and twenty-nine studies described blood analytes, one amniotic fluid analytes, 27 ultrasound features, 17 post-natal features. Among the biomarkers evaluated in exploratory studies, Adiponectin, AFABP, Betatrophin, CRP, Cystatin-C, Delta-Neutrophil Index, GGT, TNF-A were those demonstrating statistically and clinically significant differences in substantial cohorts of patients (> 500). Regarding biomarkers assessed versus OGTT (i.e. potential OGTT alternatives) most promising were Leptin > 48.5 ng/ml, Ficolin3/adiponectin ratio ≥ 1.06, Chemerin/FABP > 0.71, and Ultrasound Gestational Diabetes Score > 4. These all demonstrated sensitivity and specificity > 80% in adequate sample sizes (> / = 100).Conclusions: Numerous biomarkers may differentiate GDM from normoglycaemic pregnancy. Given the limitations of the OGTT and the lack of a gold standard for GDM diagnosis, advanced phase studies are needed to triangulate the most promising biomarkers. Further studies are also recommended to assess the sensitivity and specificity of promising biomarkers not yet assessed against OGTT.Trial registration: PROSPERO registration number CRD42020145499.Keywords
This publication has 136 references indexed in Scilit:
- CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational DiabetesPLOS ONE, 2012
- Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitusGynecological Endocrinology, 2012
- Gestational Diabetes Mellitus Causes Changes in the Concentrations of Adipocyte Fatty Acid–Binding Protein and Other Adipocytokines in Cord BloodDiabetes Care, 2011
- Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitusDiabetes & Metabolism, 2010
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in PregnancyDiabetes Care, 2010
- Fetal umbilical arterial and venous Doppler measurements in gestational diabetic and nondiabetic pregnancies near termThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Hyperglycemia and Adverse Pregnancy Outcome (HAPO) StudyDiabetes, 2009
- Australian carbohydrate intolerance study in pregnant women: implications for the management of gestational diabetesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Triangulation as a basis for diagnostic judgmentsInternational Journal of Sport and Exercise Psychology, 2003
- Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injuryJournal of Molecular and Cellular Cardiology, 1995